GWM
CBT icon

Geneos Wealth Management’s Cabot Corp CBT Stock Holding History

Geneos Wealth Management’s Portfolio CBT Stock Details CBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-521
Closed -$39.1K – 2596
2025
Q2 		$39.1K Sell
521
-585
-53% -$44.8K ﹤0.01% 1709
2025
Q1 		$92K Buy
1,106
+1,017
+1,143% +$87.7K ﹤0.01% 1614
2024
Q4 		$8.13K Buy
89
+15
+20% +$1.61K ﹤0.01% 2136
2024
Q3 		$8.27K Buy
+74
New +$7.37K ﹤0.01% 1904
2024
Q2 		– Sell
-18
Closed -$1.66K – 2075
2024
Q1 		$1.66K Buy
+18
New +$1.46K ﹤0.01% 1926

Other funds holding CBT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Geneos Wealth Management's CBT Position: Q3 2025 in Review

Geneos Wealth Management sold out of Cabot Corp (CBT) in Q3 2025, closing a stake of 521 shares — an estimated $39.1K sold.

Geneos Wealth Management first reported a position in CBT in Q1 2024 and held it in 5 quarters. The position peaked at $92K in Q1 2025. 378 funds tracked by Wall St. Rank hold CBT as of Q3 2025.

  • Geneos Wealth Management reported no remaining Cabot Corp position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 521 Cabot Corp shares in Q3 2025, an estimated $39.1K.
  • Geneos Wealth Management first reported a position in Cabot Corp in Q1 2024 and held it in 5 quarters.
  • Geneos Wealth Management's Cabot Corp position peaked at $92K in Q1 2025.
  • 378 funds tracked by Wall St. Rank held Cabot Corp as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.